The billionaire recently bought an obesity drug stock that could soar nearly 20% over the next 12 months, according to Wall ...
Vipin Garg, Altimmune CEO, joins 'Fast Money' to discuss Altimmune announcing topline results from its obesity drug trial, ...
Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made ...
(Reuters) - Eli Lilly said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in Pleasant ...
In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the ...
Azelaprag, the company’s main clinical candidate, is an oral apelin receptor agonist designed to amplify the weight loss ...
Battling obesity requires a shift away from today’s reactive efforts. Enter Robert F. Kennedy Jr., the controversial nominee ...
Eli Lilly, the US pharmaceutical giant that gained widespread attention globally with its weight-loss treatments, plans to ...
Results from a recent survey have prompted questions about the influence of GLP-1s on the obesity rate of U.S. adults.
The biotech disclosed Friday plans to terminate a Phase 2 study testing azelaprag with tirzepatide for weight loss following ...
After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets ...
BioAge Labs said on Friday it is discontinuing the mid-stage trial of its experimental obesity drug after high levels of ...